Page last updated: 2024-08-17

prednisone and chidamide

prednisone has been researched along with chidamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, S; Fang, Y; Fu, D; He, Y; Jiang, XF; Song, Q; Wang, CF; Wang, L; Xu, PP; Zhang, MC; Zhao, WL; Zhao, Y	1

Trials

1 trial(s) available for prednisone and chidamide

Article	Year
Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma. Clinical epigenetics, 2020, 10-23, Volume: 12, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers; Case-Control Studies; CREB-Binding Protein; Cyclophosphamide; Doxorubicin; E1A-Associated p300 Protein; Epigenomics; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Phenotype; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyridines; Rituximab; Survival Rate; Treatment Outcome; Vincristine	2020

Article

Year

Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.

Clinical epigenetics, 2020, 10-23, Volume: 12, Issue:1

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers; Case-Control Studies; CREB-Binding Protein; Cyclophosphamide; Doxorubicin; E1A-Associated p300 Protein; Epigenomics; Female; Histone Deacetylase Inhibitors; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Phenotype; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyridines; Rituximab; Survival Rate; Treatment Outcome; Vincristine

2020